Celecoxib's generic name is celecoxib [1].
When Does Celecoxib's Patent Expire?
Information regarding the specific patent expiry dates for celecoxib is available through resources like DrugPatentWatch.com [2]. Patent expiry dates are crucial for determining when generic versions of a drug can enter the market.
Who Makes Generic Celecoxib?
Multiple pharmaceutical companies manufacture generic versions of celecoxib once the patent protection for the originator drug expires. These companies produce bioequivalent versions of the medication.
How Does Generic Celecoxib Compare to Brand-Name Celecoxib?
Generic celecoxib is required to be bioequivalent to the brand-name version. This means it contains the same active ingredient, dosage form, strength, and route of administration, and it is expected to have the same clinical effect and safety profile [3]. The primary difference is typically in the inactive ingredients and cost.
What Conditions Does Celecoxib Treat?
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with several conditions. These include osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea [4].
What are the Risks and Side Effects of Celecoxib?
Like other NSAIDs, celecoxib carries risks, including an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke. It can also increase the risk of gastrointestinal perforation, ulceration, and bleeding. Common side effects can include stomach pain, diarrhea, indigestion, gas, headache, and upper respiratory tract infection [4].
Are There Alternatives to Celecoxib?
Alternative treatments for pain and inflammation include other NSAIDs (e.g., ibuprofen, naproxen), acetaminophen, and in some cases, corticosteroids or disease-modifying antirheumatic drugs (DMARDs) for inflammatory conditions [5]. The choice of alternative depends on the specific condition being treated and individual patient factors.
How Much Does Generic Celecoxib Cost?
The cost of generic celecoxib is typically significantly lower than the brand-name version. Prices can vary based on the pharmacy, dosage, and insurance coverage [6].
What is the Mechanism of Action for Celecoxib?
Celecoxib works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme. COX-2 is involved in the production of prostaglandins, which mediate pain, inflammation, and fever. By inhibiting COX-2, celecoxib reduces the synthesis of these prostaglandins [4].
Can Biosimilars Enter Before Patent Expiry?
Generally, biosimilars are relevant for biologic drugs, not small-molecule drugs like celecoxib. For small-molecule drugs, generic versions enter the market after the expiration of patents and any other forms of market exclusivity [2][7].
What is the Regulatory Status of Celecoxib?
Celecoxib is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for its indicated uses. Generic versions must also meet strict FDA standards for safety, quality, and efficacy before they can be approved and marketed [3][8].
What are the Key Differences Between COX-1 and COX-2 Inhibitors?
Celecoxib is a selective COX-2 inhibitor. Traditional NSAIDs inhibit both COX-1 and COX-2 enzymes. COX-1 is involved in protecting the stomach lining and supporting platelet function, while COX-2 is primarily induced at sites of inflammation. Selective COX-2 inhibition aims to reduce inflammation and pain with a potentially lower risk of gastrointestinal side effects compared to non-selective NSAIDs, although cardiovascular risks remain a concern [4][9].
---
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.fda.gov/drugs/generic-drugs/what-generic-drug-information
4. https://www.rxlist.com/consumercelebrexadvilvscelebrex/drugs-conditions.htm
5. https://www.nhs.uk/medicines/celecoxib/
6. https://www.goodrx.com/celecoxib
7. https://www.fda.gov/drugs/biosimilars/biosimilar-product-biosimilar-and-interchangeable-product-information
8. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder
9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674657/